Haritoglou C, Kampik A
Augenklinik, Ludwig-Maximilians-Universität, München.
Ophthalmologe. 2004 Jun;101(6):618-24. doi: 10.1007/s00347-004-1027-z.
At the end of the nineteenth century, "macular edema" had already been recognized as a pathological condition. The main causes for macular edema are vascular, inflammatory, degenerative, and congenital diseases or trauma. The therapeutic approaches have changed along with the increasing knowledge on the underlying causes of action during the last few years and include laser treatment as well as surgical interventions. Pars plana vitrectomy (including ILM peeling) seems beneficial in cases of macular edema that are associated with alterations of the vitreous or the vitreoretinal interface. For the treatment of chronic macular edema, intravitreal application of agents such as triamcinolone has become an option.
在19世纪末,“黄斑水肿”就已被确认为一种病理状态。黄斑水肿的主要病因包括血管性、炎症性、退行性、先天性疾病或创伤。在过去几年里,随着对潜在作用机制认识的不断增加,治疗方法也发生了变化,包括激光治疗以及手术干预。玻璃体视网膜界面或玻璃体改变相关的黄斑水肿病例,采用玻璃体切除术(包括内界膜剥除)似乎有益。对于慢性黄斑水肿的治疗,玻璃体内注射曲安奈德等药物已成为一种选择。